Benabente, Helfseth P.

HRN: 28-96-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
CEFTRIAXONE 1G (VIAL)
05/10/2026
05/16/2026
IV
2G
OD
HEPATIC PATHOLOGY
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines